Authors:
Smith, AJ
Wehner, JS
Manley, HJ
Richardson, AD
Beal, J
Bryant, PJ
Citation: Aj. Smith et al., Current role of beta-adrenergic blockers in the treatment of chronic congestive heart failure, AM J HEAL S, 58(2), 2001, pp. 140-145
Citation: Hj. Manley et Gr. Bailie, Effects of intraperitoneal cefazolin on mesothelial cells in noninfected CAPD patients, PERIT DIA I, 21(1), 2001, pp. 83-85
Citation: Hj. Manley et al., Comparing meditation use in two hemodialysis units against national dialysis databases, AM J HEAL S, 57(9), 2000, pp. 902-906
Authors:
Manley, HJ
Bailie, GR
Frye, R
Hess, LD
McGoldrick, MD
Citation: Hj. Manley et al., Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis, J AM S NEPH, 11(7), 2000, pp. 1310-1316
Authors:
Manley, HJ
Bailie, GR
Frye, R
McGoldrick, MD
Citation: Hj. Manley et al., Intermittent intravenous piperacillin pharmacokinetics in automated peritoneal dialysis patients, PERIT DIA I, 20(6), 2000, pp. 686-693
Citation: Rj. Elwell et al., Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics, PERIT DIA I, 20(6), 2000, pp. 694-698
Authors:
Manley, HJ
Bailie, GR
Asher, RD
Eisele, G
Frye, RF
Citation: Hj. Manley et al., Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients, PERIT DIA I, 19(1), 1999, pp. 65-70